Monsanto Roundup Lawsuit Settlement Update for October 2026

Bayer's Monsanto unit is still waiting for final court approval of its $7.25 billion Roundup settlement, with a fairness hearing held September 14, 2026, and no written ruling yet as of early October. At the same time, a June 2026 Supreme Court decision and a new jury trial that opened September 29 mean Roundup litigation now runs on two separate tracks with different rules. For anyone who used Roundup and was diagnosed with non-Hodgkin's lymphoma, understanding which track applies determines whether a claim can still be filed, what it might pay, and how long payment could take.

Table of Contents

• What Is the $7.25 Billion Settlement, and Who Does It Cover?
• Why Hasn't the Settlement Been Finally Approved Yet?
• How Did the Supreme Court's June Ruling Change the Picture?
• What's Happening With Lawsuits Outside the Settlement?
• What Should Someone With a Pending or Potential Claim Do Now?
• Frequently Asked Questions

What Is the $7.25 Billion Settlement, and Who Does It Cover?

Monsanto proposed the $7.25 billion nationwide class settlement in February 2026, filed as *King v. Monsanto* in St. Louis, Missouri Circuit Court, to resolve current and future Roundup non-Hodgkin's-lymphoma claims through a capped-payment program that runs up to 21 years, according to Insurance Journal and Bloomberg Law reporting. The deal is estimated to cover roughly 65,000 current and future claimants nationwide, according to Drugwatch.

Judge Timothy Boyer granted preliminary approval on March 4-5, 2026. Individual payouts are set to range from roughly $10,000 to $165,000, depending on cancer severity, age at diagnosis, and exposure history, according to the Genetic Literacy Project. The settlement also includes a walk-away provision: Monsanto can withdraw from the deal if too many class members opt out instead of participating, per Drugwatch. That provision is one reason the opt-out decision carries real weight for anyone weighing it.

Why Hasn't the Settlement Been Finally Approved Yet?

Objectors tried to move the case into federal court on May 22, 2026. U.S. District Judge Henry Edward Autrey ruled on June 17, 2026, that non-defendant objectors had no authority to remove the case, and sent it back to Missouri state court, clearing the way for Judge Boyer to resume approval proceedings, according to Farms.com/DTN. That set up the final fairness hearing, held September 14, 2026, in St.

Louis. Objectors argued at the hearing that the tiered payout structure undervalues claims. Bayer took the matter under advisement, and no written ruling had been issued as of the most recent reporting in early October 2026, per the Genetic Literacy Project. Until Judge Boyer rules, no payments go out. Anyone included in the class should expect the review period to continue and should not assume a payout date yet.

How Did the Supreme Court's June Ruling Change the Picture?

The U.S. Supreme Court ruled 7-2 in Monsanto's favor in *Monsanto Co. v. Durnell* on June 25, 2026.

The Court held that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the federal law governing pesticide labeling, preempts state-law failure-to-warn claims because the EPA-approved label controls unless the EPA itself requires a change, according to a Dorsey & Whitney client alert. Bayer's own litigation statement frames the ruling as grounds to seek dismissal of pending warning-based Roundup claims and to bar new ones, according to Bayer's media statement. The ruling addresses only the legal question of preemption; it does not decide whether glyphosate, the herbicide's active ingredient, causes cancer. That distinction matters for anyone considering a new claim based on an inadequate-warning theory: the legal path for that specific argument has narrowed sharply, separate from the underlying science dispute.

What's Happening With Lawsuits Outside the Settlement?

Not every claimant is covered by the class deal. A new Roundup jury trial opened September 29, 2026, in a separate St. Louis courtroom, brought by three women who opted out of the class settlement.

Their suit alleges Monsanto's Roundup was defectively designed and inadequately tested, according to Insurance Journal. That case shows the opt-out track is still active even while the Durnell preemption ruling makes warning-based claims harder to win. A design-defect or inadequate-testing claim is a different legal theory than a failure-to-warn claim, which is why it can still proceed in front of a jury.

What Should Someone With a Pending or Potential Claim Do Now?

As of October 2026, people with Roundup claims sit on one of two tracks, and the practical steps differ: Anyone unsure which category applies should get that determination from an attorney handling Roundup litigation, since eligibility and claim value depend on individual diagnosis date, exposure history, and whether a claim was already filed in the class action.

• If already part of the class settlement: no action is needed to receive payment, but payment only follows Judge Boyer's final approval, which had not been issued as of early October 2026.
• If weighing whether to opt out: review the capped payout range (roughly $10,000-$165,000) against an individual trial's potential verdict, and account for the walk-away provision that lets Monsanto exit the deal if opt-outs run high.
• If considering a new claim based on failure to warn: expect that argument to face the Durnell preemption ruling, which narrows that specific legal theory nationwide.
• If considering a new claim based on defective design or inadequate testing: that theory is not foreclosed by Durnell, as the September 29 trial of opted-out plaintiffs shows.

Frequently Asked Questions

Has the $7.25 billion Roundup settlement been finally approved?

Not as of early October 2026. A fairness hearing was held September 14, 2026, but Judge Boyer had not issued a written ruling.

Does the Supreme Court's Durnell ruling end all new Roundup lawsuits?

No. It narrows failure-to-warn claims under FIFRA preemption but does not bar design-defect or inadequate-testing claims, which are still being tried.

Can someone still opt out of the class settlement?

The settlement structure includes an opt-out path, which three plaintiffs used before their trial opened September 29, 2026, but it includes a walk-away provision if too many class members opt out.

You Might Also Like

• Monsanto Roundup Lawsuit Settlement Payout Update for October 2026
• Roundup Lawsuit October 2026 Settlement Update Explained
• Monsanto Roundup Lawsuit Settlement Payouts Explained

Browse more: Active MDL Cases | Arbitration | Attorneys | Claims | Comparisons